Royce Micro-Cap Trust Files Definitive Proxy Statement

TL;DR

Royce Micro-Cap Trust filed its DEF 14A proxy statement on Aug 8, 2024. Standard shareholder info.

AI Summary

Royce Micro-Cap Trust, Inc. filed its definitive proxy statement on August 8, 2024, for the fiscal year ending December 31, 2024. The filing, designated as DEF 14A, is a standard disclosure for public companies regarding their annual shareholder meetings and related matters. The company's principal executive offices are located at 745 Fifth Avenue, New York, NY 10151.

Why It Matters

This filing provides shareholders with essential information regarding the company's governance, executive compensation, and proposals to be voted on at the upcoming annual meeting, impacting their investment decisions.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing, which is a standard disclosure document for public companies and does not inherently present new risks.

Key Numbers

• 20240808 — Filing Date (The date the definitive proxy statement was filed with the SEC.)
• 20241231 — Fiscal Year End (The end date of the fiscal year for which the proxy statement provides information.)

Key Players & Entities

• ROYCE MICRO-CAP TRUST, INC. (company) — Registrant
• 745 FIFTH AVENUE (location) — Business Address
• New York (location) — City
• 10151 (location) — ZIP Code

FAQ

Filing Documents

• g102523_rmt.htm (DEF 14A) — 259KB
• img005_v2.jpg (GRAPHIC) — 147KB
• img006_v2.jpg (GRAPHIC) — 204KB
• img007_v2.jpg (GRAPHIC) — 361KB
• img008_v2.jpg (GRAPHIC) — 178KB
• 0000949377-24-000113.txt ( ) — 1486KB

financial statements be included in the Fund’s 2023 Annual Report to Stockholders

financial statements be included in the Fund’s 2023 Annual Report to Stockholders. Nominating Committee The Board has a Nominating Committee (the “Nominating Committee”) composed of the six Independent Directors, namely Ms. Chadwick, Ms. Harper, and Ms. Poston, and Messrs. Grisanti, O’Brien, and Shields. Mr. O’Brien currently serves as the Chair of the Nominating Committee. The Board has adopted a Nominating Committee charter for the Fund, a copy of which was included as an exhibit to the Proxy Statement for the Fund’s 2022 Annual Meeting of Stockholders. A copy of the Nominating Committee charter for the Fund may be obtained by calling 1-800-221-4268 . The Nominating Committee is responsible for identifying and recommending to the Board individuals believed to be qualified to become Board members in the event that a position is vacated or created. The Nominating Committee will consider Director candidates recommended by stockholders. In considering potential nominees, the Nominating Committee will take into consideration (i) the contribution which the person can make to the Board, with consideration given to the person’s business and professional experience, education and such other factors as the Committee may consider relevant, including but not limited to whether a potential nominee’s personal and professional qualities and attributes would provide a beneficial diversity of skills, experience and/or perspective to the Board; (ii) the character and integrity of the person; (iii) whether or not the person is an “interested person” as defined in the Investment Company Act and whether the person is otherwise qualified under applicable laws and regulations to serve as a Director or Independent Director of the Fund; (iv) whether or not the person has any relationships that might impair his or her independence, such as any business, financial or family relationships with Fund management, the investment a

View Full Filing

View this DEF 14A filing on SEC EDGAR